[
    [
        {
            "time": "2018-11-30",
            "original_text": "收盘突破年线个股一览",
            "features": {
                "keywords": [
                    "收盘",
                    "突破",
                    "年线",
                    "个股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "收盘突破年线个股一览",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-12-01",
            "original_text": "乐普医疗:氯吡格雷通过一致性评价,市场份额有望快速提升",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "氯吡格雷",
                    "一致性评价",
                    "市场份额",
                    "提升"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "乐普医疗:氯吡格雷通过一致性评价,市场份额有望快速提升",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-12-02",
            "original_text": "【华泰医药代雯团队】乐普医疗 (300003.SZ, 买入) 事件点评：氯吡格雷通过一致性评价，有望受益带量采购",
            "features": {
                "keywords": [
                    "华泰医药",
                    "乐普医疗",
                    "氯吡格雷",
                    "一致性评价",
                    "带量采购"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【华泰医药代雯团队】乐普医疗 (300003.SZ, 买入) 事件点评：氯吡格雷通过一致性评价，有望受益带量采购",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-12-03",
            "original_text": "乐普医疗（300003）重大事件快评：氯吡格雷通过一致性评价，抓住改革机遇抢占市场",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "氯吡格雷",
                    "一致性评价",
                    "改革",
                    "市场"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗（300003）重大事件快评：氯吡格雷通过一致性评价，抓住改革机遇抢占市场",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-12-04",
            "original_text": "乐普医疗：氯吡格雷通过一致性评价 望受益于带量采购试点",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "氯吡格雷",
                    "一致性评价",
                    "带量采购",
                    "试点"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗：氯吡格雷通过一致性评价 望受益于带量采购试点",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-12-05",
            "original_text": "30股获券商买入评级 平高电气目标涨幅达52.09%",
            "features": {
                "keywords": [
                    "券商",
                    "买入评级",
                    "平高电气",
                    "目标涨幅"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "电力设备"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "30股获券商买入评级 平高电气目标涨幅达52.09%",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-06",
            "original_text": "乐普医疗公告点评:氯吡格雷顺利通过一致性评价,静待政策利好",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "氯吡格雷",
                    "一致性评价",
                    "政策",
                    "利好"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗公告点评:氯吡格雷顺利通过一致性评价,静待政策利好",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]